|
| General factors | |
|
| (1) “One-size-fits-all” approach not applicable | |
| (a) All geriatric patients ≠ | |
| (2) Physiology | |
| (a) Renal decline | |
| (b) Hepatic decline | |
| (c) Body muscle/fat composition change | |
| (3) Perception of pain varies | |
| (4) Cognitive impairment | |
| (a) Medication literacy decline | |
| (b) Confusion about what, when, and how much | |
| medication to take | |
| (5) Comorbidities | |
| (a) Interactions with medications | |
| (b) Require multiple medications | |
| (6) Polypharmacy | |
| (a) Confusion about what, when, and how much | |
| medication to take | |
| (b) Overdosing | |
| (c) Drug-drug interactions | |
| (7) Age-related factors interactions with medication | |
| (a) Increased susceptibility | |
| (b) Atypical presentation | |
| (c) Delayed/lack of detection | |
| (8) Evidence-based practices | |
| (a) Lack of a roadmap to optimally manage pain | |
| (9) Multiplicity of providers and lack of team approach to | |
| managing health conditions in the elderly | |
| (a) Multiple physicians prescribing | |
| (b) Pharmacists | |
| (c) Self/consumer | |
| (d) Insurance companies | |
| (10) Cost/coverage of medications | |
|
